X T L Biopharmaceuticals Ltd (XTLB) Technical Analysis
$1.88▲6.82%
Market is closed - opens 8 PM, 26 Dec 2024
Insights
- X T L Biopharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for X T L Biopharmaceuticals stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, X T L Biopharmaceuticals stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for X T L Biopharmaceuticals stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 55.11 | Neutral |
Stochastic | 71.88, 42.71 | Neutral |
Ultimate Oscillator | 76.82 | Sell |
Stochastic Relative Strength Index | 61.2, 29.69 | Neutral |
Moving Average Convergence Divergence | -0.07, -0.07 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.67 | Sell |
20 | 1.76 | Sell |
50 | 1.83 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.69 | Sell |
20 | 1.73 | Sell |
50 | 1.89 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.64 | Buy |
20 | 1.77 | Buy |
50 | 1.83 | Neutral |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.66 | Buy |
20 | 1.65 | Buy |
50 | 1.62 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 1.68 | Buy |
20 | 1.65 | Buy |
50 | 1.62 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 2.0 |
Resistance L2 | 1.88 |
Resistance L1 | 1.82 |
Pivot Point | 1.7 |
Support L1 | 1.64 |
Support L2 | 1.52 |
Support L3 | 1.46 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.